Pfizer Recalling Thermacare Heat Wraps In USVI, Puerto Rico and U.S. Mainland
NEW YORK — Pfizer Consumer Healthcare has issued a nationwide recall for some of its Thermacare heat wraps because there is a possibility that the contents can leak out of the wrap.
“The use of a leaking/damaged heat cell wrap could cause skin injuries such as burns/blisters and/or skin irritation on the wrap applied area,” said the FDA.
Six different wraps are being pulled from shelves, including Thermacare wraps for muscle pain, joint-muscle pain, and menstrual pain.
They were sold in the United States mainland, Puerto Rico, and the U.S. Virgin Islands from September 2017 to August 2018.
If you have one of the recalled wraps, Pfizer says to stop using it, record the lot number, throw it away and call them at 1-800-323-3383 for a replacement or reimbursement.
For a full list of the recalled items, visit the FDA’s website
Pfizer said some of their ThermaCare HeatWrap products because they could leak ingredients and cause skin burns and blisters.
For much more information from the FDA, visit https://www.fda.gov/Safety/Recalls/ucm626671.htm
From the U.S. Food & Drug Administration:
Pfizer Consumer Healthcare, a division of Pfizer Inc., is voluntarily recalling six lots of ThermaCare® HeatWrap product to the consumer level. Pfizer Consumer Healthcare initiated this recall because product from these lots has a potential to leak ingredients that are contained in the heat cell wrap.
The use of a leaking/damaged heat cell wrap could cause skin injuries such as burns/blisters and/or skin irritation on the wrap applied area. The product label warns not to use the product if heat cell contents leak and/or the wrap is damaged or torn.
ThermaCare® Muscle Pain Therapy provides heat therapy for temporary relief of minor muscular aches and pains associated with overexertion, strains, sprains, and arthritis. ThermaCare® Menstrual Pain Therapy provides heat therapy for temporary relief of minor menstrual cramp pain and associated backaches.
The ThermaCare® HeatWrap lots impacted are S68516 (Muscle Pain Therapy 3+1 count carton), T26686 (Muscle Pain Therapy 3 count carton), T26691 (Menstrual Pain Therapy 3 count carton), T26693 (Menstrual Pain Therapy 3+1 count carton); and 8054HA and 8054HB (11 count bundled packages contain one (1) package of Muscle Therapy Heatwraps, 8HR (3 Count) and two (2) packages of Joint Therapy Heatwraps, 8HR (4 Count)). Please note ThermaCare® Joint Therapy Heatwraps, 8HR are not subject to this recall notification.
These lots were distributed nationwide to retailers, wholesalers and distributors in the United States, Puerto Rico and the U.S. Virgin Islands from September 2017 through August 2018.
Pfizer Inc. places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process.
Pfizer Consumer Healthcare is notifying consumers of this recall with this public notification. Pfizer Consumer Healthcare has already notified its retailers of this recall on October 2, 2018 and has provided instructions for the return of any recalled product. Wholesalers, distributors and retailers with an existing inventory of the lot being recalled should stop use and distribution and quarantine the product immediately.
Wholesalers, distributors and retailers who have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. For retailer instructions on returning product or additional assistance, call Stericycle at 1-800-805-3093 between the hours of 8 a.m. to 5 p.m. ET, Monday through Friday.